Morales, Anecita .

HRN: 29-11-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/12/2026
06/19/2026
IV
2.25g
Q8h
CELLULITIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: